Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial) - Braat, A JAT; Kwekkeboom, D J; Kam, B LR (BMC Gastroenterol, 2018)